Conference Coverage

Chemotherapy Ordering Management System

Kelley MJ, Retland DD, Harrison D.

Abstract 23: 2014 AVAHO Meeting


 

References

Purpose: The VHA has one of the largest and fastest growing cancer populations in the country. In 2009, there were 157,166 chemotherapy orders placed for 25,493 patients. Currently, the VHA clinical oncology environment uses a mixture of paper-based and computer-based practices with limited direct order entry of chemotherapy. The lack of order entry standardization often results in errors, adverse events, and inefficiencies. The purpose for creating the Chemotherapy Ordering Management System (COMS) is to provide an automated solution that will enhance capabilities, minimize errors, and meet the needs of VHA oncology services.

Methods: Oncology is a uniquely high-risk and high-complexity domain of health care that has not been effectively implemented in the existing electronic health record (EHR)—VistA. Unfortunately, oncology practices are hindered by the lack of specialized functionality within VA’s EHR. The CPRS lacks critical functions required for oncology. This creates a clinical environment that lacks standardization and limited direct order entry of chemotherapy. COMS is a web-based application that supports oncology health care teams in ordering, preparing, and documenting the administration of chemotherapy. COMS consists of a general application interface and several modules—Chemotherapy Template Order Source, Order Entry Management, Flow Sheet, Nursing Documentation, and End of Treatment Summary—that serve a specific purpose and provide functionality to support users in executing their roles and responsibilities in the treatment process. COMS interfaces and interacts with existing VHA clinical systems, modules and processes within CPRS and VistA. Specifically, COMS interacts with VA databases by retrieving patient information and writing pertinent information to provide 1 interface for entering information regarding the provision of oncology services to a patient. COMS will be deployed at 2 locations: the Durham VA Medical Center in Durham, North Carolina, and the VA Puget Sound Health Care System in Seattle and Tacoma, Washington. The cost of setting up and maintaining a chemotherapy commercial off-the-shelf (COTS) product within VHA is about $19,355,259 the first year and $1,429,638 every subsequent year. Field-testing will begin in the fall of 2014. COMS is currently being tested in the VHA test environment to make necessary changes to the application for enhanced clinical functionality and compliance with latest VA security guidelines and Office of Information & Technology (OI&T) site requirements. The use of COMS, as opposed to acquiring a COTS product, will create significant cost savings for VA.

Conclusions: The cost of setting up and maintaining a chemotherapy COTS product is estimated to be $19,355,259 in the first year and $1,429,638 in subsequent years. The already-developed COMS application only needs to be deployed to existing oncology sites and supported by existing staff. COMS is a government-furnished application that is the sole property of VA. It is a readily-deployable application that provides an enterprise tool for VHA Oncology Services nationwide. The Chemotherapy Ordering Management System is intended to be a safe and effective medication management system integrated into the VA EHR, allowing users to auto calculate treatment dosage, construct and share treatment plans, create standardized order sets for national use, document treatments given, respond to toxicities and follow-up recommendations at the conclusion of the course of therapy, reduce errors, and rework and improving efficiencies.

Recommended Reading

Oral Antineoplastic Therapy Adherence and Adverse Events: A Quality Assessment Project at the Providence VAMC
AVAHO
VHA and Reproductive Health: Addressing Fertility Risk Factors and Preservation Options for Veterans With Cancer
AVAHO
Implementation of the Cancer Care Coordination Program in the Veterans Affairs Hospital: Sharing Our Experience and What We Have Learned
AVAHO
Using Reminder Dialog Templates to Monitor Cancer Care
AVAHO
Reproducible Complete Remission of Advanced Hepatocellular Carcinoma With Sorafenib in Combination With Clopidogrel
AVAHO
Systemic Therapy Use in Stage IV Pancreatic Cancer: Comparison Between VA Nebraska-Western Iowa and National Database, Using National Cancer Data Base Analysis
AVAHO
National Cancer Care Cube
AVAHO
Becoming a Paperless Radiation Oncology Department: LEAN Six Sigma Thinking in the VA System
AVAHO
Evaluation and Implementation of a Standardized Approach to Supportive Care Management for Veterans Receiving Intravenous Chemotherapy
AVAHO
Trend of Esophageal Squamous Cell Carcinoma in the 21st Century: An Analysis of the SEER 18 Database
AVAHO